Molecular Testing and the Pathologist's Role in Clinical Trials of Breast Cancer

Clinical Breast Cancer- United States

doi 10.1016/j.clbc.2016.02.016

Full Text

Abstract

Available in

Categories

Cancer Research

Date

June 1, 2016

Authors

Anthony M. Magliocco

Publisher

Elsevier BV

Related search

Molecular Pathways: Preclinical Models and Clinical Trials With Metformin in Breast Cancer

Clinical Cancer Research

Cancer Research

English

The Role of Cytology in Molecular Testing and Personalized Medicine in Lung Cancer: A Clinical Perspective

Cancer cytopathology

Cancer Research

English

Immunotherapeutic Strategies in Breast Cancer: Preclinical and Clinical Trials

English

Role of Nab-Paclitaxel in Metastatic Breast Cancer: A Meta-Analysis of Randomized Clinical Trials

English

Patient Barriers to Participation in Breast Cancer Clinical Trials

Breast Cancer Management

Nuclear Medicine

English

Introducing Breast Cancer Research's Updates on Clinical Trials

Breast Cancer Research

Cancer Research

English

Molecular Profiling of Breast Cancer: Clinical Implications

British Journal of Cancer

Cancer Research

English

Identification of Accrual Barriers Onto Breast Cancer Prevention Clinical Trials

Cancer Research

English

Molecular Genomic Testing for Breast Cancer: Utility for Surgeons

Annals of Surgical Oncology

English